Industry: Chemical & Material
Published Date: 2025-02-14
Pages: 94 Pages
Report ld: 3778926
Request Sample
Customized Report
Pharmaceutical Grade Niacin Market Size(US$)

CAGR 2025-2031
5.1%
Market Size,2031
USD 922
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Pharmaceutical Grade Niacin was valued at US$ 653 million in the year 2024 and is projected to reach a revised size of US$ 922 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Niacin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Niacin.
The Pharmaceutical Grade Niacin market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Grade Niacin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Grade Niacin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Grade Niacin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical Grade Niacin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical Grade Niacin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Pharmaceutical Grade Niacin Market Overview
1.1 Product Definition
1.2 Pharmaceutical Grade Niacin by Type
1.2.1 Global Pharmaceutical Grade Niacin Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Crystal
1.2.3 Powder
1.3 Pharmaceutical Grade Niacin by Application
1.3.1 Global Pharmaceutical Grade Niacin Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceutical Industry
1.3.3 Daily Chemicals
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pharmaceutical Grade Niacin Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pharmaceutical Grade Niacin Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pharmaceutical Grade Niacin Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Niacin Production Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical Grade Niacin Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pharmaceutical Grade Niacin, Industry Ranking, 2023 VS 2024
2.4 Global Pharmaceutical Grade Niacin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharmaceutical Grade Niacin Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pharmaceutical Grade Niacin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical Grade Niacin, Product Offered and Application
2.8 Global Key Manufacturers of Pharmaceutical Grade Niacin, Date of Enter into This Industry
2.9 Pharmaceutical Grade Niacin Market Competitive Situation and Trends
2.9.1 Pharmaceutical Grade Niacin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharmaceutical Grade Niacin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharmaceutical Grade Niacin Production by Region
3.1 Global Pharmaceutical Grade Niacin Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pharmaceutical Grade Niacin Production Value by Region (2020-2031)
3.2.1 Global Pharmaceutical Grade Niacin Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pharmaceutical Grade Niacin by Region (2026-2031)
3.3 Global Pharmaceutical Grade Niacin Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pharmaceutical Grade Niacin Production Volume by Region (2020-2031)
3.4.1 Global Pharmaceutical Grade Niacin Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pharmaceutical Grade Niacin by Region (2026-2031)
3.5 Global Pharmaceutical Grade Niacin Market Price Analysis by Region (2020-2025)
3.6 Global Pharmaceutical Grade Niacin Production and Value, Year-over-Year Growth
3.6.1 North America Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2020-2031)
4 Pharmaceutical Grade Niacin Consumption by Region
4.1 Global Pharmaceutical Grade Niacin Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pharmaceutical Grade Niacin Consumption by Region (2020-2031)
4.2.1 Global Pharmaceutical Grade Niacin Consumption by Region (2020-2025)
4.2.2 Global Pharmaceutical Grade Niacin Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pharmaceutical Grade Niacin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pharmaceutical Grade Niacin Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical Grade Niacin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pharmaceutical Grade Niacin Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical Grade Niacin Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pharmaceutical Grade Niacin Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical Grade Niacin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pharmaceutical Grade Niacin Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharmaceutical Grade Niacin Production by Type (2020-2031)
5.1.1 Global Pharmaceutical Grade Niacin Production by Type (2020-2025)
5.1.2 Global Pharmaceutical Grade Niacin Production by Type (2026-2031)
5.1.3 Global Pharmaceutical Grade Niacin Production Market Share by Type (2020-2031)
5.2 Global Pharmaceutical Grade Niacin Production Value by Type (2020-2031)
5.2.1 Global Pharmaceutical Grade Niacin Production Value by Type (2020-2025)
5.2.2 Global Pharmaceutical Grade Niacin Production Value by Type (2026-2031)
5.2.3 Global Pharmaceutical Grade Niacin Production Value Market Share by Type (2020-2031)
5.3 Global Pharmaceutical Grade Niacin Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pharmaceutical Grade Niacin Production by Application (2020-2031)
6.1.1 Global Pharmaceutical Grade Niacin Production by Application (2020-2025)
6.1.2 Global Pharmaceutical Grade Niacin Production by Application (2026-2031)
6.1.3 Global Pharmaceutical Grade Niacin Production Market Share by Application (2020-2031)
6.2 Global Pharmaceutical Grade Niacin Production Value by Application (2020-2031)
6.2.1 Global Pharmaceutical Grade Niacin Production Value by Application (2020-2025)
6.2.2 Global Pharmaceutical Grade Niacin Production Value by Application (2026-2031)
6.2.3 Global Pharmaceutical Grade Niacin Production Value Market Share by Application (2020-2031)
6.3 Global Pharmaceutical Grade Niacin Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Lonza
7.1.1 Lonza Pharmaceutical Grade Niacin Company Information
7.1.2 Lonza Pharmaceutical Grade Niacin Product Portfolio
7.1.3 Lonza Pharmaceutical Grade Niacin Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Lonza Main Business and Markets Served
7.1.5 Lonza Recent Developments/Updates
7.2 Jubilant Life Sciences
7.2.1 Jubilant Life Sciences Pharmaceutical Grade Niacin Company Information
7.2.2 Jubilant Life Sciences Pharmaceutical Grade Niacin Product Portfolio
7.2.3 Jubilant Life Sciences Pharmaceutical Grade Niacin Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Jubilant Life Sciences Main Business and Markets Served
7.2.5 Jubilant Life Sciences Recent Developments/Updates
7.3 Vertellus
7.3.1 Vertellus Pharmaceutical Grade Niacin Company Information
7.3.2 Vertellus Pharmaceutical Grade Niacin Product Portfolio
7.3.3 Vertellus Pharmaceutical Grade Niacin Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Vertellus Main Business and Markets Served
7.3.5 Vertellus Recent Developments/Updates
7.4 Brother Enterprises
7.4.1 Brother Enterprises Pharmaceutical Grade Niacin Company Information
7.4.2 Brother Enterprises Pharmaceutical Grade Niacin Product Portfolio
7.4.3 Brother Enterprises Pharmaceutical Grade Niacin Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Brother Enterprises Main Business and Markets Served
7.4.5 Brother Enterprises Recent Developments/Updates
7.5 Zhejiang Lanbo Biotechnology
7.5.1 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Company Information
7.5.2 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Product Portfolio
7.5.3 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Zhejiang Lanbo Biotechnology Main Business and Markets Served
7.5.5 Zhejiang Lanbo Biotechnology Recent Developments/Updates
7.6 Lasons India
7.6.1 Lasons India Pharmaceutical Grade Niacin Company Information
7.6.2 Lasons India Pharmaceutical Grade Niacin Product Portfolio
7.6.3 Lasons India Pharmaceutical Grade Niacin Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Lasons India Main Business and Markets Served
7.6.5 Lasons India Recent Developments/Updates
7.7 Vanetta
7.7.1 Vanetta Pharmaceutical Grade Niacin Company Information
7.7.2 Vanetta Pharmaceutical Grade Niacin Product Portfolio
7.7.3 Vanetta Pharmaceutical Grade Niacin Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Vanetta Main Business and Markets Served
7.7.5 Vanetta Recent Developments/Updates
7.8 DSM
7.8.1 DSM Pharmaceutical Grade Niacin Company Information
7.8.2 DSM Pharmaceutical Grade Niacin Product Portfolio
7.8.3 DSM Pharmaceutical Grade Niacin Production, Value, Price and Gross Margin (2020-2025)
7.8.4 DSM Main Business and Markets Served
7.8.5 DSM Recent Developments/Updates
7.9 Tianjin Zhongrui Pharmaceutical
7.9.1 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Company Information
7.9.2 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Product Portfolio
7.9.3 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Tianjin Zhongrui Pharmaceutical Main Business and Markets Served
7.9.5 Tianjin Zhongrui Pharmaceutical Recent Developments/Updates
7.10 Resonance Specialties
7.10.1 Resonance Specialties Pharmaceutical Grade Niacin Company Information
7.10.2 Resonance Specialties Pharmaceutical Grade Niacin Product Portfolio
7.10.3 Resonance Specialties Pharmaceutical Grade Niacin Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Resonance Specialties Main Business and Markets Served
7.10.5 Resonance Specialties Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical Grade Niacin Industry Chain Analysis
8.2 Pharmaceutical Grade Niacin Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical Grade Niacin Production Mode & Process Analysis
8.4 Pharmaceutical Grade Niacin Sales and Marketing
8.4.1 Pharmaceutical Grade Niacin Sales Channels
8.4.2 Pharmaceutical Grade Niacin Distributors
8.5 Pharmaceutical Grade Niacin Customer Analysis
9 Pharmaceutical Grade Niacin Market Dynamics
9.1 Pharmaceutical Grade Niacin Industry Trends
9.2 Pharmaceutical Grade Niacin Market Drivers
9.3 Pharmaceutical Grade Niacin Market Challenges
9.4 Pharmaceutical Grade Niacin Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 683 million in 2025 and is projected to reach US$ 965 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 105
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Niacin market was valued at US$ 683 million in 2025 and is anticipated to reach US$ 965 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 134
USD 2900.00
(Single User License)
The global Pharmaceutical Grade Niacin market is projected to grow from US$ 653 million in 2024 to US$ 922 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 136
USD 4900.00
(Single User License)
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 91
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Niacin market size was US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 80
USD 4250.00
(Single User License)
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published Date: 2024-02-05
Pages: 96
USD 2900.00
(Single User License)
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published Date: 2024-01-25
Pages: 122
USD 3950.00
(Single User License)
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 683 million in 2025 and is projected to reach US$ 965 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-02-01
Pages: 105
The global Pharmaceutical Grade Niacin market was valued at US$ 683 million in 2025 and is anticipated to reach US$ 965 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-02-01
Pages: 134
The global Pharmaceutical Grade Niacin market is projected to grow from US$ 653 million in 2024 to US$ 922 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 136
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 91
The global Pharmaceutical Grade Niacin market size was US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 80
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published: 2024-04-10
Pages: 112
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published: 2024-02-05
Pages: 96
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published: 2024-01-25
Pages: 122
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now